These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

719 related articles for article (PubMed ID: 15181200)

  • 1. The Parkinson's disease protein DJ-1 is neuroprotective due to cysteine-sulfinic acid-driven mitochondrial localization.
    Canet-Avilés RM; Wilson MA; Miller DW; Ahmad R; McLendon C; Bandyopadhyay S; Baptista MJ; Ringe D; Petsko GA; Cookson MR
    Proc Natl Acad Sci U S A; 2004 Jun; 101(24):9103-8. PubMed ID: 15181200
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Formation of a stabilized cysteine sulfinic acid is critical for the mitochondrial function of the parkinsonism protein DJ-1.
    Blackinton J; Lakshminarasimhan M; Thomas KJ; Ahmad R; Greggio E; Raza AS; Cookson MR; Wilson MA
    J Biol Chem; 2009 Mar; 284(10):6476-85. PubMed ID: 19124468
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of single amino acid substitution on oxidative modifications of the Parkinson's disease-related protein, DJ-1.
    Madian AG; Hindupur J; Hulleman JD; Diaz-Maldonado N; Mishra VR; Guigard E; Kay CM; Rochet JC; Regnier FE
    Mol Cell Proteomics; 2012 Feb; 11(2):M111.010892. PubMed ID: 22104028
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monomer DJ-1 and its N-terminal sequence are necessary for mitochondrial localization of DJ-1 mutants.
    Maita C; Maita H; Iguchi-Ariga SM; Ariga H
    PLoS One; 2013; 8(1):e54087. PubMed ID: 23326576
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Separation of native and C106-oxidized DJ-1 proteins by using column chromatography.
    Choi J; Yoo HJ; Cho K; Kim HN; Lee JH; Ryu KS
    Protein Expr Purif; 2022 Aug; 195-196():106092. PubMed ID: 35430350
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mitochondrial localization of DJ-1 leads to enhanced neuroprotection.
    Junn E; Jang WH; Zhao X; Jeong BS; Mouradian MM
    J Neurosci Res; 2009 Jan; 87(1):123-9. PubMed ID: 18711745
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Destabilization of DJ-1 by familial substitution and oxidative modifications: implications for Parkinson's disease.
    Hulleman JD; Mirzaei H; Guigard E; Taylor KL; Ray SS; Kay CM; Regnier FE; Rochet JC
    Biochemistry; 2007 May; 46(19):5776-89. PubMed ID: 17451229
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cysteine pKa depression by a protonated glutamic acid in human DJ-1.
    Witt AC; Lakshminarasimhan M; Remington BC; Hasim S; Pozharski E; Wilson MA
    Biochemistry; 2008 Jul; 47(28):7430-40. PubMed ID: 18570440
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of cysteine-reactive cross-linkers to probe conformational flexibility of human DJ-1 demonstrates that Glu18 mutations are dimers.
    Prahlad J; Hauser DN; Milkovic NM; Cookson MR; Wilson MA
    J Neurochem; 2014 Sep; 130(6):839-53. PubMed ID: 24832775
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conservation of oxidative protein stabilization in an insect homologue of parkinsonism-associated protein DJ-1.
    Lin J; Prahlad J; Wilson MA
    Biochemistry; 2012 May; 51(18):3799-807. PubMed ID: 22515803
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Roles of distinct cysteine residues in S-nitrosylation and dimerization of DJ-1.
    Ito G; Ariga H; Nakagawa Y; Iwatsubo T
    Biochem Biophys Res Commun; 2006 Jan; 339(2):667-72. PubMed ID: 16316629
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Specific cleavage of DJ-1 under an oxidative condition.
    Ooe H; Maita C; Maita H; Iguchi-Ariga SM; Ariga H
    Neurosci Lett; 2006 Oct; 406(3):165-8. PubMed ID: 16935423
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuroprotective function of DJ-1 in Parkinson's disease.
    Ariga H; Takahashi-Niki K; Kato I; Maita H; Niki T; Iguchi-Ariga SM
    Oxid Med Cell Longev; 2013; 2013():683920. PubMed ID: 23766857
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stepwise oxidations play key roles in the structural and functional regulations of DJ-1.
    Song IK; Kim MS; Ferrell JE; Shin DH; Lee KJ
    Biochem J; 2021 Oct; 478(19):3505-3525. PubMed ID: 34515295
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of cysteine oxidation in DJ-1 function and dysfunction.
    Wilson MA
    Antioxid Redox Signal; 2011 Jul; 15(1):111-22. PubMed ID: 20812780
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Parkinson's disease-associated DJ-1 protein is a transcriptional co-activator that protects against neuronal apoptosis.
    Xu J; Zhong N; Wang H; Elias JE; Kim CY; Woldman I; Pifl C; Gygi SP; Geula C; Yankner BA
    Hum Mol Genet; 2005 May; 14(9):1231-41. PubMed ID: 15790595
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Establishment of specific antibodies that recognize C106-oxidized DJ-1.
    Ooe H; Iguchi-Ariga SM; Ariga H
    Neurosci Lett; 2006 Aug; 404(1-2):166-9. PubMed ID: 16781058
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oxidized DJ-1 inhibits p53 by sequestering p53 from promoters in a DNA-binding affinity-dependent manner.
    Kato I; Maita H; Takahashi-Niki K; Saito Y; Noguchi N; Iguchi-Ariga SM; Ariga H
    Mol Cell Biol; 2013 Jan; 33(2):340-59. PubMed ID: 23149933
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proper SUMO-1 conjugation is essential to DJ-1 to exert its full activities.
    Shinbo Y; Niki T; Taira T; Ooe H; Takahashi-Niki K; Maita C; Seino C; Iguchi-Ariga SM; Ariga H
    Cell Death Differ; 2006 Jan; 13(1):96-108. PubMed ID: 15976810
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DJ-1, a causative gene product of a familial form of Parkinson's disease, is secreted through microdomains.
    Tsuboi Y; Munemoto H; Ishikawa S; Matsumoto K; Iguchi-Ariga SM; Ariga H
    FEBS Lett; 2008 Jul; 582(17):2643-9. PubMed ID: 18586035
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.